The overexpression of NPY driven by the CMV promoter, with an AAV vector injected intracerebroventricularly (i.c.v.), prolonged seizure latency and decreased seizure severity up to 4 weeks after the injection in the rat model of kainic acid (KA)-induced epilepsy [62]. Here, NPY is linked to epilepsy.